More on RCKT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (6.0 Score)

Upcoming Events

- Earnings (8/11/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Rocket Pharmaceuticals (NQ:RCKT)
Delayed: 4.41 -0.23 (4.96%)
Prev. Close $4.64  
Open$4.55 
52 Wk High$ 
52 Wk Low$ 
Day High$4.68 
Day Low$4.16 
P/E N/A  
EPS$ 
Volume4,533,156 

Friends, Peers and Foes (?): ASND, BBIO, INSM, MIRM, RNA (more...)

Mar 2, 2026 04:22 PM Rocket Pharmaceuticals (RCKT) files $400M mixed shelf
Mar 2, 2026 04:18 PM Form S-3 ROCKET PHARMACEUTICALS,
Mar 2, 2026 06:30 AM Rocket Pharmaceuticals (RCKT) PT Raised to $3 at Goldman Sachs
Feb 27, 2026 08:40 AM Rocket Pharmaceuticals (RCKT) PT Raised to $10 at Cantor Fitzgerald
Feb 26, 2026 05:16 PM Rocket Pharmaceuticals (RCKT) Tops Q4 EPS by 5c
Feb 26, 2026 04:25 PM Form 8-K ROCKET PHARMACEUTICALS, For: Feb 26
Feb 26, 2026 04:08 PM Form 10-K ROCKET PHARMACEUTICALS, For: Dec 31
Feb 26, 2026 04:00 PM Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Feb 23, 2026 07:00 AM Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Feb 20, 2026 04:32 PM Form 4 ROCKET PHARMACEUTICALS, For: Feb 18 Filed by: Militello John
View All Articles

Entities mentioned with RCKT

View All Entities